EFDID: 143018EFD: View Filing

Issuer: FLUOROPHARMA MEDICAL, INC. (0001402785) - D

Accession: 0001415889-15-002006 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001402785
  • Entity Name:
    FLUOROPHARMA MEDICAL, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    8 Hillside Avenue
    Suite 108
    Montclair, NJ 07042
  • Persons:
    Related Persons 7
    Johan (Thijs) M. Spoor
    Executive Officer, Director
    Tamara M. Rhein
    Executive Officer
    Walter M. Witoshkin
    Director
    Peter S. Conti
    Director
    Lawrence M. Atinsky
    Director
    Joseph A. Pierro
    Director
    Andrew H. Sassine
    Director
EDGAR: Offering Information
  • Accession Date:
    06/08/2015
  • First Sale Date:
    05/28/2015
  • Offering Amount:
    $2,000,000
  • Amount Sold:
    $350,000
  • Amount Remaining:
    $1,650,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:NJ
Inactive:CO, PR
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Merriman Capital, Inc. 18296 Highline Research Advisors LLC None CO, NJ, PR
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
FluoroPharma Medical, Inc./s/ Johan M. (Thijs) SpoorJohan M. (Thijs) SpoorCEO2015-06-08